Outcome base rates
What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.
Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.
55%patentees prevail on the merits
11 merits decisions; 24 inconclusive cases excluded (small sample)
6 won · 5 lost · ↓ 80.0pp vs. prior 12 months
Win rate by year
Patentee win rate by year of first decision.
- 2023: 100% (1/1)
- 2024: 66.7% (2/3)
- 2025: 50% (3/6)
- 2026: 0% (0/1)
Win rate by division
Top divisions by merits-decision volume.
- Mannheim LD100%(n=2)
- Dusseldorf LD100%(n=1)
- The Hague LD50%(n=6)
- Munich LD0%(n=2)
When patentees lose, why?
Of 5 losses…
60%
40%
Patent invalidated — 3 (60%)No infringement found — 2 (40%)
PI grant rate
43%
3 granted · 4 denied · 7 total decisions
PI grant rate (conservative)
43%
Granted / total PI decisions (incl. interim, withdrawn)
Infringement rate
80%
4 infringed · 1 not infringed
Revocation rate
100%
1 revoked / partially · 0 maintained / amended
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
22% 6 / 27
Outcomes by category (detailed)
Stacked breakdown using sharper outcome enums — revocation cases split into revoked_full / revoked_partial / maintained_as_*, etc.
Settlement timing
When settled or withdrawn cases actually closed — relative to procedural milestones.
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
- Infringement75
- Revocation27
- Provisional measures15
- Other13
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
- The Hague LD71 casesPI grant rate: 40%Infringement rate: 67%Revocation rate: —
- Munich LD32 casesPI grant rate: 0%Infringement rate: —Revocation rate: 100%
- Mannheim LD18 casesPI grant rate: —Infringement rate: 100%Revocation rate: —
- Dusseldorf LD8 casesPI grant rate: —Infringement rate: 100%Revocation rate: —
- Hamburg LD1 casesPI grant rate: 100%Infringement rate: —Revocation rate: —
Recent decisions
Most recent decisions in scope.
- —UPC_CFI_59/2025Costs onlyThe Munich Local Division ruled that the anti-anti-suit injunction application by Dolby International against Roku became moot after Roku voluntarily withdrew its US proceedings, declaring the application for provisional measures groundless and the earlier interim order void, with costs awarded against Roku.
- 2026-03-03UPC_CFI_43/2025The Hague LDRevokedThe Hague Local Division revoked Advanced Brain Monitoring's EP 2 437 696 B2 (position therapy device for sleep disorders) as lacking inventive step over JP748 prior art. The counterclaim for revocation by Philips succeeded and the infringement action was dismissed.
- 2026-02-25UPC_CFI_619/2025The Hague LDProcedural onlyThe Hague Local Division addressed GSK's R.263 application to amend its claim and Moderna's R.9 application to dismiss late-filed submissions in a parallel mRNA vaccine infringement action.
- 2026-02-25UPC_CFI_620/2025The Hague LDProcedural onlyThe Hague Local Division issued a procedural order under Rule 9 RoP in GSK's infringement action against Pfizer/BioNTech entities concerning vaccine-related patents, addressing admissibility of submissions in GSK's Reply.
- 2026-02-18UPC_CFI_616/2025The Hague LDProcedural onlyThe Hague Local Division ruled on GSK's application to amend its claim under Rule 263 RoP and Moderna's application to dismiss late-filed submissions under Rule 9 RoP in patent infringement proceedings relating to mRNA vaccine technology.
- 2026-02-05UPC_CFI_666/2024The Hague LDSettledThe Hague Local Division declared the proceedings closed in both the infringement claim (Adeia v. Walt Disney) and the counterclaim for revocation, following the parties' mutual withdrawal of their actions under R.265.1 RoP after reaching a settlement. The court reimbursed 40% of the court fees paid, corresponding to the stage of proceedings at time of withdrawal (after interim procedure but before oral procedure). The settlement terms were not disclosed.
- 2026-01-16UPC_CFI_1048/2025The Hague LDSettledThe Hague Local Division allowed BTL Medizintechnik GmbH's withdrawal of its infringement action against Lexter Microelectronic Engineering Systems S.L. following a settlement. The proceedings were declared closed with no cost decision required.
- 2025-12-10UPC_CFI_251/2025The Hague LDProcedural onlyThe Hague Local Division issued a case management order addressing Maxell's 44 conditional auxiliary requests in infringement proceedings against Samsung concerning EP 2 061 230, requesting clarification on the reasonable number of auxiliary requests per R. 30.1(c) RoP.